Combs Andrew Insider Trades

Insider Trading History

Track insider trading activity for Combs Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $982k 230,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 230,000 shares
$2.30
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $2.05M 480,123 shares
Last Trade
Mar 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$69k 100,000 shares
$0.69
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $747k 175,000 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 175,000 shares
$1.11
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $1.61M 377,623 shares
Last Trade
Dec 23, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$74.4k 60,000 shares
$1.24
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $1.36M 317,623 shares
Last Trade
Dec 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.54k 3,075 shares
$1.15
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Chemistry Officer
Holding Value $641k 150,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 150,000 shares
$4.59
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $576k 135,000 shares
Last Trade
Feb 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 135,000 shares
$7.20
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $215k 50,397 shares
Last Trade
Apr 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$261k 36,062 shares
$7.25
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $1.3M 304,442 shares
Last Trade
Mar 31, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$249k 36,062 shares
$6.90
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $215k 50,397 shares
Last Trade
Mar 31, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$249k 36,062 shares
$6.90
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $427k 100,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 100,000 shares
$10.58
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $1.15M 268,380 shares
Last Trade
Dec 14, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.4k 4,000 shares
$11.60
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $1.13M 264,380 shares
Last Trade
Dec 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.5k 4,000 shares
$12.12
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $406k 95,000 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.97M 95,000 shares
$31.23
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $1.11M 260,380 shares
Last Trade
Sep 29, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.8k 1,000 shares
$28.84
$4.27
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Head Of Chemistry
Holding Value $1.11M 259,380 shares
Last Trade
Sep 24, 2020 Sale
No data
No data
$4.27

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up